We are continuing to strengthen our high-throughput screening capabilities with the addition of another Qube to our lab.
This expansion of our automated patch clamp capacity not only enables us to handle higher volumes of work more efficiently, but also provides our team with further opportunities to deepen their expertise in high-throughput electrophysiology. By investing in advanced technology, we are continuously enhancing our technical capabilities, improving workflow efficiency, and ensuring the delivery of high-quality, reliable data for ion channel drug discovery projects.
As Gary Clark, PhD, Director of Ion Channel Screening, explains:
"The addition of another Qube is an important step for our laboratory. It increases our capacity and enables us to support our growing number of high-throughput screening projects for our customers."
As demand for high-throughput screening continues to grow, this latest addition positions us to support an increasing number of projects while maintaining the high standards our customers expect.
We are continuing to strengthen our high-throughput screening capabilities with the addition of another Qube to our lab.
This expansion of our automated patch clamp capacity not only enables us to handle higher volumes of work more efficiently, but also provides our team with further opportunities to deepen their expertise in high-throughput electrophysiology. By investing in advanced technology, we are continuously enhancing our technical capabilities, improving workflow efficiency, and ensuring the delivery of high-quality, reliable data for ion channel drug discovery projects.
As Gary Clark, PhD, Director of Ion Channel Screening, explains:
"The addition of another Qube is an important step for our laboratory. It increases our capacity and enables us to support our growing number of high-throughput screening projects for our customers."
As demand for high-throughput screening continues to grow, this latest addition positions us to support an increasing number of projects while maintaining the high standards our customers expect.
We are continuing to strengthen our high-throughput screening capabilities with the addition of another Qube to our lab.
This expansion of our automated patch clamp capacity not only enables us to handle higher volumes of work more efficiently, but also provides our team with further opportunities to deepen their expertise in high-throughput electrophysiology. By investing in advanced technology, we are continuously enhancing our technical capabilities, improving workflow efficiency, and ensuring the delivery of high-quality, reliable data for ion channel drug discovery projects.
As Gary Clark, PhD, Director of Ion Channel Screening, explains:
"The addition of another Qube is an important step for our laboratory. It increases our capacity and enables us to support our growing number of high-throughput screening projects for our customers."
As demand for high-throughput screening continues to grow, this latest addition positions us to support an increasing number of projects while maintaining the high standards our customers expect.